APOB and familial hyperaldosteronism: In some cases reported, FH patients displayed digenic mutations with two different heterozygous mutations in two loci at separate genes, including the involvement of LDLRAP, APOB, or PCKS9 (Moyer and Baudhuin, 2015; Figure 1).